Herszéyi et al. [13] have proved that circulating uPA can be used as better prognostic markers than the commonly used colorectal cancer markers CEA and CA 19-9 as increased uPA levels could be detected in the blood of colorectal cancer patients. The gene discussed is PLAU; the disease is colorectal cancer.